Serology study after BTN162b2 vaccination in participants previously infected with SARS-CoV-2 in two different waves versus naïve
Luca Dalle Carbonare(University of Verona), Donato Zipeto(University of Verona), Daniela Alberti(University of Verona), Natalia Tiberti(Ospedale Sacro Cuore Don Calabria), Chiara Piubelli(Ospedale Sacro Cuore Don Calabria), Jessica Bertacco(University of Verona), Laura Masin(University of Verona), Massimo Pizzato(University of Trento), Veronica Li Vigni(University of Verona), Sérgio Ferrari(University of Verona), Zeno Bisoffi(Ospedale Sacro Cuore Don Calabria), Ernesto Crisafulli(University of Verona), Gianluigi Dorelli(University of Verona), Silvia Accordini(University of Verona), Sara Mariotto(University of Verona), Arianna Minoia(University of Verona), Maria Teresa Valenti(University of Verona), Silvia Stefánia Longoni(Ospedale Sacro Cuore Don Calabria), Alberto Beretta, Lucia Lopalco(Vita-Salute San Raffaele University)
Cited by 21
Related Papers
Control of HIV despite the Discontinuation of Antiretroviral Therapy
|New England Journal of Medicine|1999|328
Immunization with HIV-1 gp41 Subunit Virosomes Induces Mucosal Antibodies Protecting Nonhuman Primates against Vaginal SHIV Challenges
|Immunity|2011|285
Three-step monoclonal antibody tumor targeting in carcinoembryonic antigen-positive patients.
|PubMed|1991|247
Mucosal and Plasma IgA from HIV-1-Exposed Uninfected Individuals Inhibit HIV-1 Transcytosis Across Human Epithelial Cells
|The Journal of Immunology|2000|244
Guillain-Barré syndrome and COVID-19: an observational multicentre study from two Italian hotspot regions
|Journal of Neurology Neurosurgery & Psychiatry|2020|199